
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)
Pari Malherbe, Olivier Roche, Anne Marcuz, et al.
Molecular Pharmacology (2010) Vol. 78, Iss. 1, pp. 81-93
Closed Access | Times Cited: 45
Pari Malherbe, Olivier Roche, Anne Marcuz, et al.
Molecular Pharmacology (2010) Vol. 78, Iss. 1, pp. 81-93
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
The role of orexin in motivated behaviours
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 203
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 203
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
Daniël Hoyer, Laura H. Jacobson
Neuropeptides (2013) Vol. 47, Iss. 6, pp. 477-488
Closed Access | Times Cited: 107
The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR–Ligand Interactions
Alexander Heifetz, Ewa I. Chudyk, Laura Gleave, et al.
Journal of Chemical Information and Modeling (2015) Vol. 56, Iss. 1, pp. 159-172
Open Access | Times Cited: 103
Alexander Heifetz, Ewa I. Chudyk, Laura Gleave, et al.
Journal of Chemical Information and Modeling (2015) Vol. 56, Iss. 1, pp. 159-172
Open Access | Times Cited: 103
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA
Ryoji Suno, Kanako Kimura, Takanori Nakane, et al.
Structure (2017) Vol. 26, Iss. 1, pp. 7-19.e5
Open Access | Times Cited: 66
Ryoji Suno, Kanako Kimura, Takanori Nakane, et al.
Structure (2017) Vol. 26, Iss. 1, pp. 7-19.e5
Open Access | Times Cited: 66
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Molecular mechanism of the wake-promoting agent TAK-925
Jie Yin, Yanyong Kang, Aaron P. McGrath, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Jie Yin, Yanyong Kang, Aaron P. McGrath, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Toward an Understanding of Agonist Binding to Human Orexin-1 and Orexin-2 Receptors with G-Protein-Coupled Receptor Modeling and Site-Directed Mutagenesis
Alexander Heifetz, Oliver Barker, G. Benjamin Morris, et al.
Biochemistry (2013) Vol. 52, Iss. 46, pp. 8246-8260
Open Access | Times Cited: 42
Alexander Heifetz, Oliver Barker, G. Benjamin Morris, et al.
Biochemistry (2013) Vol. 52, Iss. 46, pp. 8246-8260
Open Access | Times Cited: 42
Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis
Alexander Heifetz, G. Benjamin Morris, Philip C. Biggin, et al.
Biochemistry (2012) Vol. 51, Iss. 15, pp. 3178-3197
Closed Access | Times Cited: 41
Alexander Heifetz, G. Benjamin Morris, Philip C. Biggin, et al.
Biochemistry (2012) Vol. 51, Iss. 15, pp. 3178-3197
Closed Access | Times Cited: 41
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions
Alexander Heifetz, Matteo Aldeghi, Ewa I. Chudyk, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 2, pp. 574-581
Open Access | Times Cited: 32
Alexander Heifetz, Matteo Aldeghi, Ewa I. Chudyk, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 2, pp. 574-581
Open Access | Times Cited: 32
Understanding Peptide Binding in Class A G Protein-Coupled Receptors
Irina G. Tikhonova, Véronique Gigoux, Daniel Fourmy
Molecular Pharmacology (2019) Vol. 96, Iss. 5, pp. 550-561
Open Access | Times Cited: 31
Irina G. Tikhonova, Véronique Gigoux, Daniel Fourmy
Molecular Pharmacology (2019) Vol. 96, Iss. 5, pp. 550-561
Open Access | Times Cited: 31
Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 35
Gabrielle E. Callander, Morenike Olorunda, Dominique Monna, et al.
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 35
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis.
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Closed Access | Times Cited: 26
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Closed Access | Times Cited: 26
Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras
Jaana Putula, Jyrki P. Kukkonen
Neuroscience Letters (2011) Vol. 506, Iss. 1, pp. 111-115
Closed Access | Times Cited: 29
Jaana Putula, Jyrki P. Kukkonen
Neuroscience Letters (2011) Vol. 506, Iss. 1, pp. 111-115
Closed Access | Times Cited: 29
Iftakur Rahman, Bhaskar Deka, Ranjit Thakuria, et al.
Organic & Biomolecular Chemistry (2020) Vol. 18, Iss. 33, pp. 6514-6518
Closed Access | Times Cited: 21
Interaction modes of human orexin 2 receptor with selective and nonselective antagonists studied by NMR spectroscopy
Kayo Imamura, Ken‐ichi Akagi, Yohei Miyanoiri, et al.
Structure (2024) Vol. 32, Iss. 3, pp. 352-361.e5
Open Access | Times Cited: 2
Kayo Imamura, Ken‐ichi Akagi, Yohei Miyanoiri, et al.
Structure (2024) Vol. 32, Iss. 3, pp. 352-361.e5
Open Access | Times Cited: 2